Eisai and Merck succeeded in stopping Shilpa Medicare Ltd. from launching a generic version of Lenvima for at least another ...

Midi Health, the virtual care company best known for providing hormone therapy for women in menopause, is expanding to ...

Sanofi partners in Vietnam, Almac hits £1B sales, Quadria raises $1.07B, CurifyLabs gets funding, BrainStorm signs with ...

For Illumina, its former employees are both a boon and a problem. In the 27 years since its founding, the DNA sequencing ...

Oric Pharmaceuticals raises $125M for Phase 3 prostate cancer drug ORIC-944 after positive early results, with study planned ...

The companies said Thursday that they voluntarily withdrew the accelerated approval request for patritumab deruxtecan in ...

After a slight delay, the FDA rejected Stealth BioTherapeutics' Barth syndrome drug application for elamipretide, but will ...

Since Bernard Ravina's medical training in neurology in the '90s, there have been few new therapies that treat a movement ...

Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

Post-Hoc Live to discuss John Carroll's Endpoints 100 survey on biopharma industry sentiment, featuring Kyle LaHucik, ...

Taysha Gene Ther­a­pies re­veals plans for piv­otal tri­al, $200M of­fer­ing: The biotech on Wednes­day … Get free access to a limited number of articles, plus choose newsletters to get straight to ...

The US’ stance on Covid-19 vaccines under HHS chief Robert F. Kennedy Jr. is coming into focus with a new approval framework, ...